Literature DB >> 6269080

Construction and characterization of recombinant plasmid DNAs containing sequences of the origin of bacteriophage phi X174 DNA replication.

F Heidekamp, P D Baas, J H van Boom, G H Veeneman, S L Zipursky, H S Jansz.   

Abstract

The synthetic DNA fragment (formula, see text) (corresponding to nucleotides 4299-4314 of the phi X DNA sequence) was cloned into either the AmpR gene or the KmR gene of plasmid pACYC 177. The DNA sequence of the KmR gene around the insertion site was determined by nucleotide sequence analysis of the pACYC 177 FnudII restriction DNA fragment N6 (345 b.p.). Of five selected plasmid DNAs, which contained inserted DNA sequences in the antibiotic resistance genes, the nucleotide sequences at and around these insertions were determined. Two recombinant plasmids (pFH 704 and pFH 614) contain the hexadecamer sequence in tandem (tail-to-tail and tail-to-head). In the recombinant plasmids pFH 812, pFH 903 and pFH 807 the DNA sequence homology with the phi X origin region was 14 (No. 4300-4313), 16 (No. 4299-4314) and 20 nucleotides (No. 4299-4318), respectively. None of the supercoiled recombinant plasmid DNAs is nicked upon incubation with phi X gene A protein. Moreover, the recombinant plasmid RFI DNAs cannot act as substitutes for phi X RFI DNA in the in vitro (+) strand synthesizing system. It has been shown earlier that single-stranded DNA, which contains the decamer sequence CAACTTGATA is efficiently nicked by the phi X gene A protein. The present results indicate that for nicking of double-stranded supercoiled DNA nucleotide sequence homology with the phi X origin region of more than 20 nucleotides is required. These results suggest a model for initiation of phi X RF DNA replication, which involves the presence of the recognition sequence CAACTTGATA of the phi X gene A protein as well as a second specific nucleotide sequence which is required for the binding of the phi X gene A protein. This binding causes local unwinding of the DNA double helix and exposure of the recognition sequence in a single-stranded form, which then can be nicked by phi X gene A protein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269080      PMCID: PMC327355          DOI: 10.1093/nar/9.14.3335

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  PhiX174 replicative form DNA replication, origin and direction.

Authors:  P D Baas; H S Jansz
Journal:  J Mol Biol       Date:  1972-02-14       Impact factor: 5.469

2.  Locating interrupted hydrogen bonding in the secondary structure of PM2 circular DNA by comparative denaturation mapping.

Authors:  R J Jacob; J Lebowitz; A K Kleinschmidt
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

3.  Calcium-dependent bacteriophage DNA infection.

Authors:  M Mandel; A Higa
Journal:  J Mol Biol       Date:  1970-10-14       Impact factor: 5.469

4.  The process of infection with bacteriophage phi-X174. XIX. Isolation and characterization of a chloramphenicol-resistant protein from phi-X-infected cells.

Authors:  A J Levine; R L Sinsheimer
Journal:  J Mol Biol       Date:  1968-03-28       Impact factor: 5.469

5.  Conformational aspects and reactivity of DNA. Effects of manganese and magnesium ions on interaction with DNA.

Authors:  G Luck; C Zimmer
Journal:  Eur J Biochem       Date:  1972-09-25

6.  Formation of the parental replicative form DNA of bacteriophage phi-X174 and initial events in its replication.

Authors:  B Francke; D S Ray
Journal:  J Mol Biol       Date:  1971-11-14       Impact factor: 5.469

7.  Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form.

Authors:  D B Clewell; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

8.  A dye-buoyant-density method for the detection and isolation of closed circular duplex DNA: the closed circular DNA in HeLa cells.

Authors:  R Radloff; W Bauer; J Vinograd
Journal:  Proc Natl Acad Sci U S A       Date:  1967-05       Impact factor: 11.205

9.  Template activities of the phi X-174 replicative allomorphic deoxyribonucleic acids.

Authors:  Y Hayashi; M Hayashi
Journal:  Biochemistry       Date:  1971-11       Impact factor: 3.162

10.  Preparation of double-stranded DNA (replicative form) of bacteriophage phi-X174: a simplified method.

Authors:  H S Jansz; P H Pouwels; J Schiphorst
Journal:  Biochim Biophys Acta       Date:  1966-09
View more
  6 in total

1.  Gene A protein cleavage of recombinant plasmids containing the phi X174 replication origin.

Authors:  A C Fluit; P D Baas; J H Van Boom; G H Veeneman; H S Jansz
Journal:  Nucleic Acids Res       Date:  1984-08-24       Impact factor: 16.971

2.  Initiation and termination of the bacteriophage phi X174 rolling circle DNA replication in vivo: packaging of plasmid single-stranded DNA into bacteriophage phi X174 coats.

Authors:  A van der Ende; R Teertstra; P J Weisbeek
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

3.  Nucleotide sequences at the phi X gene A protein cleavage site in replicative form I DNAs of bacteriophages U3, G14, and alpha 3.

Authors:  F Heidekamp; P D Baas; H S Jansz
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

4.  Geminivirus replication origins have a modular organization.

Authors:  E P Fontes; H J Gladfelter; R L Schaffer; I T Petty; L Hanley-Bowdoin
Journal:  Plant Cell       Date:  1994-03       Impact factor: 11.277

5.  Replication of origin containing adenovirus DNA fragments that do not carry the terminal protein.

Authors:  B G van Bergen; P A van der Ley; W van Driel; A D van Mansfeld; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1983-04-11       Impact factor: 16.971

6.  Bacteriophage lambda int protein recognizes two classes of sequence in the phage att site: characterization of arm-type sites.

Authors:  W Ross; A Landy
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.